ReviewPharmaceutics2024

The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases.

Peyton High et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.